- Home
- DMAC vs ARL Comparison
DMAC vs ARL Comparison
Compare DMAC & ARL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DMAC
- ARL
- Stock Information
- Founded
- DMAC 2000
- ARL 1999
- Country
- DMAC United States
- ARL United States
- Employees
- DMAC N/A
- ARL N/A
- Industry
- DMAC Biotechnology: Pharmaceutical Preparations
- ARL Building operators
- Sector
- DMAC Health Care
- ARL Real Estate
- Exchange
- DMAC Nasdaq
- ARL Nasdaq
- Market Cap
- DMAC 224.6M
- ARL 231.0M
- IPO Year
- DMAC N/A
- ARL N/A
- Fundamental
- Price
- DMAC $5.81
- ARL $16.13
- Analyst Decision
- DMAC Strong Buy
- ARL
- Analyst Count
- DMAC 3
- ARL 0
- Target Price
- DMAC $7.00
- ARL N/A
- AVG Volume (30 Days)
- DMAC 100.7K
- ARL 5.8K
- Earning Date
- DMAC 03-18-2025
- ARL 11-07-2024
- Dividend Yield
- DMAC N/A
- ARL N/A
- EPS Growth
- DMAC N/A
- ARL N/A
- EPS
- DMAC N/A
- ARL N/A
- Revenue
- DMAC N/A
- ARL $51,029,000.00
- Revenue This Year
- DMAC N/A
- ARL N/A
- Revenue Next Year
- DMAC N/A
- ARL N/A
- P/E Ratio
- DMAC N/A
- ARL N/A
- Revenue Growth
- DMAC N/A
- ARL 0.87
- 52 Week Low
- DMAC $2.14
- ARL $12.51
- 52 Week High
- DMAC $6.41
- ARL $25.96
- Technical
- Relative Strength Index (RSI)
- DMAC 58.38
- ARL 58.09
- Support Level
- DMAC $5.25
- ARL $13.81
- Resistance Level
- DMAC $6.14
- ARL $14.63
- Average True Range (ATR)
- DMAC 0.38
- ARL 0.74
- MACD
- DMAC 0.02
- ARL 0.15
- Stochastic Oscillator
- DMAC 73.81
- ARL 100.00
About DMAC DiaMedica Therapeutics Inc.
DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1.
About ARL American Realty Investors Inc.
American Realty Investors Inc is a real estate company. The company acquires, develops, and owns income-producing residential and commercial real estate properties. Its segment involves the Residential segment and the Commercial segment. The residential segment is engaged in the acquisition, development, ownership, and management of multifamily properties and the Commercial segment is engaged in the acquisition, ownership, and management of commercial real estate properties. Its holdings include apartments, office buildings, retail centers, and parcels of land.